SRNE
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Christopher L. JacobsHouse · R · NY |
SRNESRNE · Stock |
Sale $1,001 - $15,000 |
Feb 17, 2021 | Jan 4, 2021 | Filing ↗ |
Christopher L. JacobsHouse · R · NY |
SRNESRNE · Stock |
Purchase $1,001 - $15,000 |
Feb 10, 2021 | Dec 28, 2020 | Filing ↗ |
Whale Activity
- Increased4
- New0
- Held1
- Decreased1
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 39.4M | $34.9M | increased |
| Vanguard Group | 29.5M | $26.2M | increased |
| D. E. Shaw & Co., Inc. | 5.1M | $4.5M | increased |
| Two Sigma Investments, LP | 302.0K | $268K | held |
| Citadel Advisors LLC | 200.1K | $177K | decreased |
| Millennium Management LLC | 742.0K | $657 | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Ji HenrySee Remarks · Director | Exercise | +300 | $5.50 | $2K | Dec 21, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Grant / award | +1.5M | $0.00 | $0 | Dec 15, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Exercise | +200 | $5.50 | $1K | Dec 2, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Purchase | +88.9K | $2.02 | $180K | Sep 7, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Purchase | +55.6K | $1.96 | $109K | Sep 6, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Grant / award | +2.5M | $0.00 | $0 | Sep 2, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Purchase | +33.3K | $2.11 | $70K | Aug 26, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Purchase | +22.2K | $2.06 | $46K | Aug 25, 2022 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Purchase | +10.0K | $1.40 | $14K | Jun 14, 2022 | Form 4 ↗ |
| Janda KimDirector | Sale | −3,000 | $5.88 | $18K | Dec 27, 2021 | Form 4 ↗ |
| Janda KimDirector | Option exercise | +3,000 | $4.00 | $12K | Dec 27, 2021 | Form 4 ↗ |
| Ji HenrySee Remarks · Director | Option exercise | +10.0K | $4.00 | $40K | Sep 29, 2021 | Form 4 ↗ |
| Janda KimDirector | Sale | −42.4K | $8.02 | $340K | Sep 27, 2021 | Form 4 ↗ |
| Janda KimDirector | Option exercise | +7,357 | $3.57 | $26K | Sep 27, 2021 | Form 4 ↗ |
| Janda KimDirector | Option exercise | +35.0K | $1.80 | $63K | Sep 27, 2021 | Form 4 ↗ |
| Janda KimDirector | Sale | −8,000 | $8.04 | $64K | Sep 13, 2021 | Form 4 ↗ |
| Janda KimDirector | Option exercise | +8,000 | $3.50 | $28K | Sep 13, 2021 | Form 4 ↗ |
| Smith Robin LDirector | Option exercise | +100.0K | $4.89 | $489K | Sep 3, 2021 | Form 4 ↗ |
| Smith Robin LDirector | Option exercise | +75.0K | $3.95 | $296K | Sep 3, 2021 | Form 4 ↗ |
| Janda KimDirector | Sale | −1,900 | $6.97 | $13K | Apr 12, 2021 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Guggenheim Active Allocation Fund | 3,481 | $2 | 0.00% | May 29, 2026 |
Mutual funds and ETFs whose N-PORT filings list SRNE's shares (CUSIP 83587F202), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming SRNE as the client.
Government Contracts
No federal contract awards found for SRNE.
U.S. Patents
No USPTO patent applications found for SRNE.
Annual Financials
No annual XBRL figures on record for SRNE. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
- 1-for-25Reverse splitAug 1, 2013
- 1-for-10Reverse splitOct 7, 2008
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
No 8-K filings on record.
About SRNE
No company profile on record.

